Sector
PharmaceuticalsOpen
₹64.65Prev. Close
₹66.55Turnover(Lac.)
₹47.5Day's High
₹67.5Day's Low
₹63.2552 Week's High
₹82.9552 Week's Low
₹64.25Book Value
₹0Face Value
₹10Mkt Cap (₹ Cr.)
72.14P/E
20.16EPS
3.22Divi. Yield
0No Record Found
Y/e 31 Mar( In .Cr) | Mar-2024 |
---|---|
Equity Capital | 4 |
Preference Capital | 0 |
Reserves | 1.49 |
Net Worth | 5.49 |
Minority Interest |
No Record Found
No Record Found
No Record Found
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,677.6 | 94.02 | 4,02,680.39 | 2,000.46 | 0.95 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,612 | 79.46 | 1,75,531.81 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,465.7 | 24.02 | 1,18,307.2 | 1,485.4 | 1.09 | 4,254.47 | 397.44 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,174.7 | 56.38 | 1,07,416.07 | 474 | 1.01 | 2,385 | 224.33 |
Dr Reddys Laboratories Ltd DRREDDY | 1,251.2 | 19.53 | 1,04,452.95 | 1,200.7 | 0.64 | 5,546.3 | 345.81 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Executive Director
Mayur Popatlal Sojitra
Director & CFO
Harshad Nanubhai Rathod
Managing Director
Vivek Ashok Kumar Patel
Executive Director
Hardik Mukundbhai Prajapati
Independent Director
Shyam Bhadresh Kapadia.
Independent Director
Vijay Bharatbhai Anadkat
Independent Director
Grishma A Shewale
Company Sec. & Compli. Officer
Bhavika Dhaval Makadia
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Accretion Pharmaceuticals Ltd
Summary
Accretion Pharmaceuticals was incorporated in year 2012, the Promoters Mr. Harshad Nanubhai Rathod, Mr. Vivek Ashok Kumar Patel, Mr. Mayur Popatlal Sojitra and Mr. Hardik Mukundbhai Prajapati, came together to establish a pharmaceutical manufacturing unit, to provide health care products. Thus, the foundation of Accretion Pharmaceuticals was laid down, which was started as a Partnership Firm in the name of M/s Accretion Pharmaceuticals, pursuant to a deed of partnership dated December 18, 2012. The manufacturing facility which is currently located at Ahmedabad, in Sanand District of Gujarat, commenced its manufacturing operations in year 2014. Thereafter, the Partnership Firm was converted into a Limited Company in the name of Accretion Pharmaceuticals Limited and a certificate of incorporation dated November 29, 2023 was issued by the Registrar of Companies, Central Registration Centre, for and on behalf of the jurisdictional Registrar of Companies.Presently, Company is engaged in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel, Lotion, Medicated Shampoo, Mouthwash, Dusting Powder), And Oral Powder (Sachet, Dry Syrup) etc. either for direct sales, loan licence and/or contract manufacturing.The Company is ISO 9001:2015, ISO 14001:2015 and ISO 22000:2018 certified and is led by a experienced board of directors, and a professional and experienced management team with extensive experience in the pharmace
Read More
The Accretion Pharmaceuticals Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹64.9 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Accretion Pharmaceuticals Ltd is ₹72.14 Cr. as of 30 May ‘25
The PE and PB ratios of Accretion Pharmaceuticals Ltd is 20.16 and 1.89 as of 30 May ‘25
The 52-week high/low is the highest and lowest price at which a Accretion Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Accretion Pharmaceuticals Ltd is ₹64.25 and ₹82.95 as of 30 May ‘25
Accretion Pharmaceuticals Ltd's CAGR for 5 Years at N/I%, 3 Years at N/I%, 1 Year at N/I%, 6 Month at N/I%, 3 Month at N/I% and 1 Month at -21.76%.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.